Related Experiment Videos
Serologic HLA-DR typing is not sufficient for definition of class II compatibility
E Möller1, B Carlsson, J Wallin
1Department of Clinical Immunology, Huddinge Hospital, Sweden.
Transplantation Proceedings
|June 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Plasma concentrations of etonogestrel in women using oral desogestrel before and after Roux-en-Y gastric bypass surgery: a pharmacokinetic study.
BJOG : an international journal of obstetrics and gynaecology·2018
Translational Modeling to Guide Study Design and Dose Choice in Obesity Exemplified by AZD1979, a Melanin-concentrating Hormone Receptor 1 Antagonist.
CPT: pharmacometrics & systems pharmacology·2017
High target attainment for β-lactam antibiotics in intensive care unit patients when actual minimum inhibitory concentrations are applied.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
Effects of three-nucleon forces and two-body currents on Gamow-Teller strengths.
Physical review letters·2015
Influence of CYP2D6 and CYP2C19 genotypes on venlafaxine metabolic ratios and stereoselective metabolism in forensic autopsy cases.
The pharmacogenomics journal·2014
Demographic, Clinical, and Allocation Shifts in the US Lung Transplant Waitlist: A National SRTR Study (2012-2023).
Transplantation proceedings·2026
Global Status and Research Trends of Heart Transplantation: A Bibliometrics Analysis.
Transplantation proceedings·2026
Apoptosis-Related Molecular Signatures in Calcineurin Inhibitor Nephrotoxicity After Kidney Transplantation.
Transplantation proceedings·2026
Transcatheter Aortic Valve Replacement or Medical Treatment for Paradoxical Low-Flow, Low-Gradient Aortic Valve Stenosis: REBOOT-PARADOX.
Journal of the American College of Cardiology·2026
A multicenter prospective observational cohort study to improve diagnostic yield and clinical management of persons with a Bleeding Disorder of Unknown Cause (BDUC-iN study protocol).
Research and practice in thrombosis and haemostasis·2026
Avatrombopag in thrombopoietin receptor agonist-naïve patients with immune thrombocytopenia: real-world treatment patterns and clinical outcomes from the REAL-AVA 3.0 study.
Research and practice in thrombosis and haemostasis·2026
Retraction: Targeted plasmalogen supplementation: effects on blood plasmalogens, oxidative stress biomarkers, cognition, and mobility in cognitively impaired persons.
Frontiers in cell and developmental biology·2026